Patent ID: 9545425
Date: 2017-01-17
CPC Classifications: A61K,B01J,C08F

Claim:
1. A pharmaceutical composition comprising: i) about 89% to about 94.5% of a calcium salt of a crosslinked potassium binding polymer having the following structure: wherein the ratio of “m” and “n” provides having 1.6% to 1.9% cross-linking; ii) about 0.6% to about 1.6% of calcium citrate tetrahydrate; iii) about 0.02% to about 0.5% of anhydrous citric acid; iv) about 0.1% to about 1% of sucralose; v) about 0.6% to about 1.6% of vanillin powder; vi) about 2.5% to about 3.5% of methyl cellulose; and vii) about 1.6% to about 2.6% of titanium dioxide.